Gambia vs South Africa: Population requiring preventive chemotherapy for schistosomiasis
Gambia
657,160
in 2024
South Africa
506,732
in 2024
Gambia rank
37th
South Africa rank
39th
Population requiring preventive chemotherapy for schistosomiasis over time
- Gambia
- South Africa
How they compare
Gambia currently reports 657,160 against 506,732 in South Africa, a difference of 150,428.
That makes Gambia's figure about 1.3 times South Africa's.
The two have swapped places 1 time across 15 shared years of data; in 2010 it was South Africa ahead.
Gambia ranks 37th and South Africa ranks 39th of 52 countries.
South Africa has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Gambia | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 158,622 | 5.28 million | 5.12 million | South Africa |
| 2020s | 439,450 | 2.98 million | 2.54 million | South Africa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Gambia or South Africa?
- Gambia, at 657,160 against 506,732 in South Africa as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Gambia and South Africa?
- 150,428, with Gambia ahead.
- How many years of comparable data are there for Gambia and South Africa?
- 15 years are reported by both, from 2010 to 2024.
- How do Gambia and South Africa rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Gambia ranks 37th and South Africa ranks 39th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.